Abstract
Chlamydiae are important human pathogens which are leading causative agents for a variety of disease conditions including ocular, respiratory and sexually transmitted diseases, thus causing significant morbidity worldwide. Many of the human diseases caused by Chlamydia species are considered to be immunopathologically mediated. Toll like receptors (TLRs) have emerged as one of the major components of the immune system. Recognition of pathogen associated molecular patterns (PAMPs) by TLRs results in the activation of signaling events that induce the expression of effector molecules such as cytokines and chemokines which control the activation of adaptive immune responses. The precise immune mechanisms involved in resistance or pathogenesis to chlamydial infection, especially in the TLR signaling and downstream events during the innate phase of infection initiating the adaptive immune responses remains largely unknown. This review focuses on elaborating the current knowledge on the role of TLRs in immune responses to chlamydial infection. Although chlamydial components like lipopolysaccharide (LPS) and chlamydial heat shock protein 60 (cHSP60) are recognized by TLR4, the intact organisms stimulates the innate immune cells through TLR2, which also plays an important role as a PRR for Chlamydia. While the individual role of different TLRs such as TLR2, TLR4 and TLR9 in chlamydial infection is becoming delineated, studies have demonstrated the essential role of the TLR adapter molecule MyD88 in the generation of immune responses to Chlamydia infection. Given that there is no effective vaccine available for Chlamydia till date, a better understanding of the immunological and molecular mechanisms mediated by TLRs will greatly aid in possibly exploiting these molecules as immunotherapeutic targets.
Keywords: Chlamydia, Toll-like receptor, MyD88
Current Pharmaceutical Design
Title: Role of Toll-Like Receptors in Immune Responses to Chlamydial Infections
Volume: 14 Issue: 6
Author(s): Xi Yang and A. G. Joyee
Affiliation:
Keywords: Chlamydia, Toll-like receptor, MyD88
Abstract: Chlamydiae are important human pathogens which are leading causative agents for a variety of disease conditions including ocular, respiratory and sexually transmitted diseases, thus causing significant morbidity worldwide. Many of the human diseases caused by Chlamydia species are considered to be immunopathologically mediated. Toll like receptors (TLRs) have emerged as one of the major components of the immune system. Recognition of pathogen associated molecular patterns (PAMPs) by TLRs results in the activation of signaling events that induce the expression of effector molecules such as cytokines and chemokines which control the activation of adaptive immune responses. The precise immune mechanisms involved in resistance or pathogenesis to chlamydial infection, especially in the TLR signaling and downstream events during the innate phase of infection initiating the adaptive immune responses remains largely unknown. This review focuses on elaborating the current knowledge on the role of TLRs in immune responses to chlamydial infection. Although chlamydial components like lipopolysaccharide (LPS) and chlamydial heat shock protein 60 (cHSP60) are recognized by TLR4, the intact organisms stimulates the innate immune cells through TLR2, which also plays an important role as a PRR for Chlamydia. While the individual role of different TLRs such as TLR2, TLR4 and TLR9 in chlamydial infection is becoming delineated, studies have demonstrated the essential role of the TLR adapter molecule MyD88 in the generation of immune responses to Chlamydia infection. Given that there is no effective vaccine available for Chlamydia till date, a better understanding of the immunological and molecular mechanisms mediated by TLRs will greatly aid in possibly exploiting these molecules as immunotherapeutic targets.
Export Options
About this article
Cite this article as:
Yang Xi and Joyee G. A., Role of Toll-Like Receptors in Immune Responses to Chlamydial Infections, Current Pharmaceutical Design 2008; 14 (6) . https://dx.doi.org/10.2174/138161208783885344
DOI https://dx.doi.org/10.2174/138161208783885344 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Non-Lipid Effects of Statins: Emerging New Indications
Current Vascular Pharmacology Lipids as Key Players in Alzheimer Disease - Alterations in Metabolism and Genetics
Current Alzheimer Research Leukopenia Associated with Risperidone Treatment
Current Drug Safety Evaluation of Pharmacokinetic Interaction of Cilostazol with Metoclopramide after Oral Administration in Human
Current Drug Metabolism Current and Future Clinical Strategies in Colon Cancer Prevention and the Emerging Role of Chemoprevention
Current Pharmaceutical Design The Role of Chemokines, Cytokines and Adhesion Molecules in Stem Cell Trafficking and Homing
Current Pharmaceutical Design Nicotine Addiction and Coronary Artery Disease: Impact of Cessation Interventions
Current Pharmaceutical Design Toll-like Receptor as a Molecular Link between Metabolic Syndrome and Inflammation: A Review
Current Drug Targets Increased Risk of Cardiovascular Complications in Chronic Kidney Disease: A Possible Role of Leptin
Current Pharmaceutical Design Metformin in the Treatment of Polycystic Ovary Syndrome
Current Pharmaceutical Design Editorial: (Thematic Issue: Vascular Pathophysiology of Alzheimer`s Disease)
Current Alzheimer Research Perioperative Management of Patients on Adenosine Diphosphate Inhibitors in the Era of Drug-Eluting Stents: Review of the Literature and Clinical Implications
Current Medicinal Chemistry Preeclampsia Prediction in Type 1 Diabetes and Diurnal Blood Pressure Methodology
Current Hypertension Reviews Diabetes, Incretin Therapy and Thoracic Aortic Aneurysm – What Does the Evidence Show?
Current Vascular Pharmacology Diagnostic Tools for Diabetic Sensorimotor Polyneuropathy
Current Diabetes Reviews Is There an Association between Periodontitis and Hypertension?
Current Cardiology Reviews Inflammatory Syndrome in Chronic Kidney Disease: Pathogenesis and Influence on Outcomes
Inflammation & Allergy - Drug Targets (Discontinued) VEGF-VEGFR System as a Target for Suppressing Inflammation and other Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Colchicine: An Old Wine in a New Bottle?
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Placental Drug Disposition and Its Clinical Implications
Current Drug Metabolism